Medtronic (MDT) Equity Ratio (2014 - 2026)

Medtronic's Equity Ratio history runs 13 years deep, the most recent figure standing at 0.54 for Q1 2026.

• In Q1 2026, Equity Ratio fell 2.48% year-over-year to 0.54; the TTM figure through Jan 2026 stood at 0.54 (down 2.48% YoY), while the FY2025 annual figure was 0.53, down 6.07% from the prior year.
• Equity Ratio came in at 0.54 for Q1 2026 at Medtronic, up from 0.53 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.59 in Q3 2022 to a low of 0.53 in Q2 2025.
• A 5-year average of 0.56 and a median of 0.56 in 2022 frame the typical range for Equity Ratio.
• Across the five-year window, Equity Ratio grew 9.67% in 2022 and dropped 6.07% in 2025, its largest moves.
• Medtronic's Equity Ratio stood at 0.56 in 2022, then advanced by 2.69% to 0.57 in 2023, then dropped by 5.63% to 0.54 in 2024, then dropped by 1.14% to 0.53 in 2025, then advanced by 0.54% to 0.54 in 2026.
• According to Business Quant data, Equity Ratio over the past three periods registered 0.54, 0.53, and 0.53 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison